Artículos por temáticas

The thalamus: Structure, function, and neurotherapeutics

Marcuse LV, Langan M, Hof PR, Panov F, Saez I, Jimenez-Shahed J, Figee M, Mayberg H, Yoo JY, Ghatan S, Balchandani P, Fields MC.

Neurotherapeutics. 2025 Feb 15:e00550. doi: 10.1016/j.neurot.2025.e00550. Online ahead of print.

Commentary on "Atypical ADCY5-related movement disorders: Highlighting adolescent/adult-onset cervical dystonia"

Ortuño-Yepes B, Martorell L, Armstrong J, Ortigoza-Escobar JD.

Parkinsonism Relat Disord. 2025 Feb 13:107327. doi: 10.1016/j.parkreldis.2025.107327. Online ahead of print.

Re-examining the pathobiological basis of gait dysfunction in Parkinson's disease

Cho N, Kalia LV, Kalia SK.

Trends Neurosci. 2025 Jan 29:S0166-2236(25)00016-5. doi: 10.1016/j.tins.2025.01.002. Online ahead of print.

Thalamic Local Field Potentials and Closed-Loop Deep Brain Stimulation in Orthostatic Tremor

Fung WKW, Sumarac S, Sorrento G, Santyr B, Milosevic L, Lang AE, Lozano AM, Kalia SK, Fasano A.

Mov Disord. 2025 Jan;40(1):141-146. doi: 10.1002/mds.30035. Epub 2024 Oct 25.

Use of vortioxetine in different neurological fields: a systematic review and future perspectives

Verrienti G, Colonna I, Raccagni C.

Neurol Sci. 2025 Jan 14. doi: 10.1007/s10072-025-07987-1. Online ahead of print.

Biallelic Variants in LIPT2 as a Cause of Infantile-Onset Dystonia: Expanding the Clinical and Molecular Spectrum

Sen K, Vera AZ, Puronurmi A, Gropman A, Wongkittichote P, Ganetzky R, Autio K, Kastaniotis A.

Pediatr Neurol. 2025 Jan;162:32-39. doi: 10.1016/j.pediatrneurol.2024.09.013. Epub 2024 Sep 18.

Changes in sensor recorded activity patterns and neuropsychiatric symptoms after deep brain stimulation for Parkinson's disease: 5 case reports

Bruhin LC, Single M, Naef AC, Petermann K, Sousa M, Castelli M, Debove I, Maradan-Gachet ME, Magalhães AD, Diamantaras AA, Lachenmayer ML, Tinkhauser G, Waskönig J, El Achkar CM, Lemkaddem A, Lemay M,

BMC Neurol. 2025 Jan 17;25(1):25. doi: 10.1186/s12883-025-04030-w.

Clinical characterization of a novel episodic ataxia in young working Cocker Spaniels

Sarró C, Stalin C, Gutierrez-Quintana R, Cloquell A.

J Vet Intern Med. 2025 Jan-Feb;39(1):e17268. doi: 10.1111/jvim.17268.

Diagnosing Huntington's disease on the medical ward

Tuan J.

BMJ Case Rep. 2025 Jan 19;18(1):e264004. doi: 10.1136/bcr-2024-264004.

Essential tremor - drug treatments present and future

Alonso-Navarro H, García-Martín E, Agúndez JAG, Jiménez-Jiménez FJ.

Expert Rev Neurother. 2025 Jan;25(1):43-56. doi: 10.1080/14737175.2024.2439514. Epub 2024 Dec 16.

Botulinum toxin treatment for hemifacial spasm: harmonising neurological and aesthetic outcomes

Maytharakcheep S, Bhidayasiri R.

J Neural Transm (Vienna). 2025 Jan;132(1):23-38. doi: 10.1007/s00702-024-02821-y. Epub 2024 Aug 23.

A rare case of adult-onset vanishing white matter leukoencephalopathy with movement disorder, expressing homozygous EIF2B3 and PRKN pathogenic variants

Douden BKA, Abufara YMA, Aldrabeeh MFA, Tell NRM, Abudaya I.

BMC Neurol. 2025 Jan 4;25(1):7. doi: 10.1186/s12883-024-04018-y.

RHOBTB2 Variant p.Arg511Gln Causes Developmental and Epileptic Encephalopathy Type 64 in an Infant: A Case Report and Hotspot Variant Analysis

Liu Q, Li F, Ruan Q, Wang N, Fan Z.

Mol Genet Genomic Med. 2025 Jan;13(1):e70059. doi: 10.1002/mgg3.70059.

Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome

Reyes NGD, Bendahan N, Swinkin E, Lang AE, Bassett AS.

Neurol Sci. 2025 Jan;46(1):463-468. doi: 10.1007/s10072-024-07705-3. Epub 2024 Jul 18.

Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial

Ferreira JJ, Rascol O, Stocchi F, Antonini A, Moreira J, Castilla-Fernández G, Rocha JF, Holenz J, Poewe W; Epsilon Study investigators.

Eur J Neurol. 2025 Jan;32(1):e16420. doi: 10.1111/ene.16420.